公告日期：2025-04-29

Company code:603939 Company abbreviation: Yifeng Pharmacy
Yifeng Pharmacy Chain Co., Ltd.

2024Annual Report

This report is prepared in both Chinese and English and is published electronically. If there is any
inconsistency between the two versions, the Chinese version shall prevail.

Important Notes

I. The Board of Directors, Board of Supervisors, directors, supervisors and senior management
of the Company hereby guarantee that the contents are authentic, accurate, and complete,
without false records, misleading representations or material omissions in the Annual Report,
and shall take all the joint and several legal liabilities.

II. All the directors have attended the meeting of the Board of Directors.

III. Pan-China Certified Public Accountants has issued a standard unqualified audit report for
the Company.

IV. Gao Yi, the Company’s responsible person, Wang Yonghui, responsible person in charge of
accounting work, and Guan Changfu, the accounting firm’s responsible person (accounting
superintendent) hereby declare and warrant that the financial report in the Annual Report is
authentic, accurate, and complete.

V. The plan of profit distribution or the conversion of capital reserves into share capital for the
Reporting Period has been approved by the Board of Directors

Based on the audit conducted by Pan-China Certified Public Accountants (special general
partnership), as of December 31, 2024, the undistributed profits in the parent company’s financial
statements amounted to CN¥854,914,834.22.

In 2024, the Company achieved a net profit attributable to the parent company amounting to CN¥ 1,
528,576,669.36.After adding the undistributed profit from the beginning of 2024, which was CN¥ 4,774
,244,419.42, and deducting the statutory surplus reserve of CN¥ 127,737,417.19 extracted at the end of
the year, along with a dividend payout of……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。